FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Hove Anders D 		2. Issuer Name and Ticker or Trading Symbol

Trubion Pharmaceuticals, Inc [ TRBN ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      __ X __ Other (specify below)
Indirect 10% owner
(Last)          (First)          (Middle)

C/O VENROCK ASSOCIATES, 30 ROCKEFELLER PLAZA, ROOM 5508 		3. Date of Earliest Transaction (MM/DD/YYYY)

5/28/2008
(Street)

NEW YORK, NY 10112
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock                  308367   I   By Venrock Partners, L.P.   (1)
Common Stock                  1512111   I   By Venrock Associates IV, L.P.   (2)
Common Stock                  37154   I   By Venrock Entrepreneurs Fund IV, L.P.   (3)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to purchase)   $6.63   5/28/2008     A     5000         (4) 5/28/2018   Common Stock   5000   $0.00   5000   D    

Explanation of Responses:
( 1)  Venrock Partners, L.P. is a limited partership, the general partner of which is Venrock Partners Management, LLC. The reporting person is a member of Venrock Partners Managment, LLC and disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
( 2)  Venrock Associates IV, L.P. is a limited partership, the general partner of which is Venrock Partners Management, LLC. The reporting person is a member of Venrock Partners Managment, LLC and disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
( 3)  Venrock Entrepreneurs Fund IV, L.P. is a limited partership, the general partner of which is VEF Management IV, LLC. The reporting person is a member of VEF Management IV, LLC and disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
( 4)  Option vests 100% on May 15, 2009, subject to the individual's provision of service to the issuer on such date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Hove Anders D
C/O VENROCK ASSOCIATES
30 ROCKEFELLER PLAZA, ROOM 5508
NEW YORK, NY 10112 		X

Indirect 10% owner

Signatures
/s/ Michelle Burris as attorney-in-fact for Anders D. Hove 5/29/2008
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Trubion Pharmaceuticals (MM) (NASDAQ:TRBN)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Trubion Pharmaceuticals (MM) Charts.
Trubion Pharmaceuticals (MM) (NASDAQ:TRBN)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Trubion Pharmaceuticals (MM) Charts.